CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusion

Marco Boeri, Anna G Purdum, Jessie Sutphin, Brett Hauber, James A Kaye

Research output: Contribution to journalArticlepeer-review

10 Downloads (Pure)

Fingerprint

Dive into the research topics of 'CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusion'. Together they form a unique fingerprint.

Medicine & Life Sciences